<SEC-DOCUMENT>0001079973-25-001080.txt : 20250630
<SEC-HEADER>0001079973-25-001080.hdr.sgml : 20250630
<ACCEPTANCE-DATETIME>20250630170028
ACCESSION NUMBER:		0001079973-25-001080
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250627
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250630
DATE AS OF CHANGE:		20250630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ascent Solar Technologies, Inc.
		CENTRAL INDEX KEY:			0001350102
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				203672603
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32919
		FILM NUMBER:		251092929

	BUSINESS ADDRESS:	
		STREET 1:		12300 GRANT STREET
		CITY:			THORNTON
		STATE:			CO
		ZIP:			80241
		BUSINESS PHONE:		(720) 872-5000

	MAIL ADDRESS:	
		STREET 1:		12300 GRANT STREET
		CITY:			THORNTON
		STATE:			CO
		ZIP:			80241
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>asti_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ASTI="http://ascentsolar.com/20250627">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_ASTI_ascentsolar.com_20250627 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250627_20250627 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001350102 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000004" name="dei:EntityCentralIndexKey">0001350102</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="asti-20250627.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001350102</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-27</xbrli:startDate>
        <xbrli:endDate>2025-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Washington, D.C.&#160;
20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>FORM <span id="xdx_908_edei--DocumentType_c20250627__20250627_zTPh8BWcfqei"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="text-transform: uppercase"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="text-transform: uppercase"><b>The
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">Date of Report (Date of
earliest event reported): <b>   <span id="xdx_907_edei--DocumentPeriodEndDate_c20250627__20250627_zo07iCYGY8og"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 27, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><span style="text-decoration: underline"></span></b></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 13.2pt 0 0; text-align: center"><span style="font-size: 18pt"><b><span id="xdx_90D_edei--EntityRegistrantName_c20250627__20250627_zKfF2Y1CrBGb"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000011" name="dei:EntityRegistrantName">ASCENT SOLAR
TECHNOLOGIES, INC.</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><span style="text-decoration: underline"></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="vertical-align: bottom; width: 28%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20250627__20250627_zuPh8sgenxcf"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; width: 5%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 34%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20250627__20250627_zdCVZM5VkdX9"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000013" name="dei:EntityFileNumber">001-32919</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; width: 5%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 28%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20250627__20250627_zD0yOOk9Lxwh"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000014" name="dei:EntityTaxIdentificationNumber">20-3672603</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="border-top: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of incorporation)</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="border-top: black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="border-top: black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: bottom">
    <td style="width: 64%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20250627__20250627_zKWRKOK4fDLc"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000015" name="dei:EntityAddressAddressLine1">12300 Grant Street</ix:nonNumeric></span></b></span></td>
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20250627__20250627_zMEVMlm6AHl1"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000016" name="dei:EntityAddressCityOrTown">Thornton</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20250627__20250627_zOM5UbwhaM24"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000017" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span> </b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressPostalZipCode_c20250627__20250627_z7V3E7dscz14"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000018" name="dei:EntityAddressPostalZipCode">80241</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;(Zip Code)</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: bottom">
    <td style="width: 27%; text-align: center; text-indent: 13.5pt">&#160;</td>
    <td style="width: 46%; padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--CityAreaCode_c20250627__20250627_zlUj4Hfj1HSf"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000019" name="dei:CityAreaCode">(720)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20250627__20250627_zBdJQ6qojkSk"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000020" name="dei:LocalPhoneNumber">872-5000</ix:nonNumeric></span></b></span></td>
    <td style="width: 27%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Registrant&#8217;s telephone number, including area code)</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Not Applicable</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">(Former name, or former
address, if changed since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_905_edei--WrittenCommunications_c20250627__20250627_zgbE0Zv3esf"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span>&#160;&#160;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90E_edei--SolicitingMaterial_c20250627__20250627_zOqPJs049n6c"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span>&#160;&#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_907_edei--PreCommencementTenderOffer_c20250627__20250627_zgGizkpr5ONg"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span>&#160;&#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20250627__20250627_zhjF34OU3ag"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span>&#160;&#160;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20250627__20250627_zsdmo8KdAFch"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000025" name="dei:Security12bTitle">Common</ix:nonNumeric></span>
    Stock, par value $0.0001 per share</span></td>
    <td>&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20250627__20250627_zv4IFUvZolCc"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000026" name="dei:TradingSymbol">ASTI</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;<span id="xdx_900_edei--SecurityExchangeName_c20250627__20250627_zPVy5uIV0D4k" style="font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> <span style="font-size: 10pt">Capital
Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Emerging growth company&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20250627__20250627_zXVpSO9AUVx4"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Securities Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 27, 2025, Ascent Solar Technologies, Inc. (the &#8220;Company&#8221;)
commenced a best efforts public offering (the &#8220;Offering&#8221;) of an aggregate of (i) 507,000 shares (the &#8220;Shares&#8221;)
of common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;), of the Company, (ii) 493,000 pre-funded warrants (the &#8220;Pre-Funded
Warrants&#8221;) to purchase up to 493,000 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;), and (iii) 1,000,000 warrants
to purchase up to 1,000,000 shares of Common Stock (&#8220;Warrants&#8221;). Each Share or Pre-Funded Warrant was sold together with one
Warrant to purchase one share of Common Stock. The combined offering price for each Share and Warrant was $2.00, and the combined offering
price for each Pre-Funded Warrant and accompanying Warrant was $1.9999. The Pre-Funded Warrants will have an exercise price of $0.0001
per share, be exercisable immediately and will expire when exercised in full. Each Warrant will have an exercise price of $2.00 per share
and will be immediately exercisable. The Warrants will expire on the five-year anniversary of the date of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><br/>
The net proceeds of the Offering, after deducting the fees and expenses of the Placement Agent (as defined below), described in more detail
below, and other offering expenses payable by the Company, but excluding the net proceeds, if any, from the exercise of the Warrants,
is expected to be approximately $1.6&#160;million.&#160;The Company intends to use the net proceeds from this offering for working capital,
product development activities, general and administrative expenses and other general corporate purposes. &#160; The Offering closed on
June 30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In connection with the Offering, the Company entered into a securities
purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain institutional investors.&#160;Pursuant to the Purchase Agreement,
the Company agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common
Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock or file any registration statement
or prospectus, or any amendment or supplement thereto for 90 days after the closing date of the Offering, subject to certain exceptions.&#160;In
addition, the Company has agreed not to effect or enter into an agreement to effect any issuance of Common Stock or any securities convertible
into or exercisable or exchangeable for shares of Common Stock involving a variable rate transaction (as defined in the Purchase Agreement)
until the one-year anniversary of the closing date of the Offering, subject to certain exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Purchase Agreement contains customary representations, warranties
and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the purchasers,
including for liabilities arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), other obligations
of the parties and termination provisions.&#160;The representations, warranties and covenants contained in the Purchase Agreement
were made only for the purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such
agreement and may be subject to limitations agreed upon by the contracting parties. A holder will not have the right to exercise any
portion of the Warrants or Pre-Funded Warrants if the holder (together with its affiliates) would beneficially own in excess of
4.99% or 9.99%, as applicable, of the number of shares of Common Stock outstanding immediately after giving effect to the exercise,
as such percentage ownership is determined in accordance with the terms of the Warrants or the Pre-Funded Warrants,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to an engagement agreement (as amended, the &#8220;Engagement
Agreement&#8221;) with H.C. Wainwright &amp; Co., LLC (the &#8220;Placement Agent&#8221;), the Company agreed to pay the Placement Agent
in connection with the Offering (i) a cash fee equal to 7.0% of the aggregate gross proceeds received in the Offering, (ii) a management
fee equal to 1.0% of the aggregate gross proceeds received in the Offering, and (iii) reimbursement of up to $100,000 for legal fees and
expenses and other out of pocket expenses. Also pursuant to the Engagement Agreement, the Company, in connection with the Offering, agreed
to issue to the Placement Agent or its designees warrants (the &#8220;Placement Agent Warrants&#8221;) to purchase up to an aggregate
of&#160;70,000&#160;shares of Common Stock (the &#8220;Placement Agent Warrant Shares&#8221;).&#160;The Placement Agent Warrants will
have an exercise price of $2.50&#160;per share (which represents&#160;125% of the combined public offering price per Share and accompanying
Warrants), will expire on June 27, 2030&#160;and will be exercisable upon issuance.<br/>
<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the
Warrants, the Warrant Shares, the Placement Agent Warrants and the Placement Agent Warrant Shares were offered by the Company pursuant
to a Registration Statement on Form S-1 (the "Registration Statement") filed with the Securities and Exchange Commission (the
&#8220;SEC&#8221;) on June 25, 2025, under the Securities Act (File No. 333-288300), and declared effective by the SEC on June 27, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The foregoing descriptions of the Purchase Agreement, the Warrants, the
Pre-Funded Warrants and the Placement Agent Warrants are not complete and are qualified in their entirety by reference to the full text
of the form of Purchase Agreement, the form of Warrant,  the form of Pre-Funded Warrant, and the form of Placement Agent Warrant, copies
of which are filed as Exhibits 10.1, 4.1, 4.2 and 4.3, respectively, to this Current Report on Form 8-K and are incorporated herein by
reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">This Current Report on Form 8-K does not constitute an offer to sell any
securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction
in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any
such state or jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Press Release</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 27, 2025, the Company issued a press release announcing the pricing
of the Offering. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated
by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%">&#160;</td>
    <td style="width: 11%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 84%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.1pt"><b>(d)</b></td>
    <td style="padding: 1.1pt"><b>Exhibits</b></td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.1pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.1pt"><b>Exhibit</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 1.1pt"><b>Number</b></p></td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.1pt; text-align: center"><b>Description</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">4.1</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt"><a href="ex4x1.htm">Form of Warrant</a></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">4.2</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt"><a href="ex4x2.htm">Form of Pre-Funded Warrant</a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">4.3</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt"><a href="ex4x3.htm">Form of Placement Agent Warrant</a></td></tr>
  <tr style="background-color: White">
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: top">10.1</td>
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: top"><a href="ex10x1.htm">Form of Securities Purchase Agreement</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: top">99.1</td>
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: top"><a href="ex99x1.htm">Press Release, dated June 27, 2025</a></td></tr>
  <tr style="background-color: White">
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: top">104</td>
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: top">Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 26.4pt 0 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 13.2pt 0 0; text-indent: 26.4pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="9">&#160;</td></tr>
  <tr>
    <td colspan="3" style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.1pt; vertical-align: bottom">&#160;</td>
    <td colspan="3" style="padding: 1.1pt; vertical-align: top">ASCENT SOLAR TECHNOLOGIES, INC.</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="padding: 1.1pt">&#160;</td>
    <td colspan="2" style="padding: 1.1pt">&#160;</td>
    <td colspan="2" style="padding: 1.1pt">&#160;</td>
    <td colspan="2" style="padding: 1.1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="padding: 1.1pt"> June 30, 2025</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">By:</td>
    <td style="border-bottom: black 1pt solid; padding: 1.1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.1pt">/s/ Jin Jo</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.1pt; width: 1%">&#160;</td>
    <td style="padding: 1.1pt; width: 1%">&#160;</td>
    <td style="padding: 1.1pt; width: 41%">&#160;</td>
    <td style="padding: 1.1pt; width: 1%">&#160;</td>
    <td style="padding: 1.1pt; width: 1%">&#160;</td>
    <td style="padding: 1.1pt; width: 1%">&#160;</td>
    <td style="padding: 1.1pt; width: 5%">&#160;</td>
    <td style="padding: 1.1pt; width: 5%">&#160;</td>
    <td style="padding: 1.1pt; width: 44%">Name: Jin Jo</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">&#160;</td>
    <td style="padding: 1.1pt">Title: Chief  Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.16
<SEQUENCE>2
<FILENAME>ex4x1.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">Exhibit 4.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ASCENT
SOLAR TECHNOLOGIES, INC.</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: ______&#9;&#9;</TD>
  <TD STYLE="text-align: right; width: 50%; vertical-align: top">&#9;Issue Date:&nbsp;______, 2025</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: right; vertical-align: top">Initial Exercise Date: ______, 2025</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">THIS COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on ______, <SUP>1 </SUP> (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for
and purchase from Ascent Solar Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares
(as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase
price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 1</U></FONT><U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (the &ldquo;<U>OTCQB</U>&rdquo;)
or the OTCQX Best Market (the &ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on the OTCQB or the OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on the OTCQB or the OTCQX and if prices for the Common Stock are then reported on The Pink Open Market operated by the OTC
Markets, Inc. (the &ldquo;<U>Pink Market</U>&rdquo;) (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common
Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the </FONT>Warrants
<FONT STYLE="background-color: white">then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%"><SUP>1</SUP></FONT>
Insert the date that is the five (5) year anniversary of the Issue Date, provided that, if such date is not a Trading Day,
insert the immediately following Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-1 (File No. 333-288300) filed with the Commission, including
all information, documents and exhibits filed with or incorporated by reference into such registration statement, as amended from
time to time, which registers the sale of the Warrants and the Warrant Shares, among others, to the purchasers, and includes any
Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo;
means the subsidiaries of the Company set forth on <U>Exhibit 21.1</U> to the Registration Statement and shall, where applicable, also
include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Trading Market on which the Common Stock is then listed is open for trading.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Computershare Investor Services, LLC, the current transfer agent of the Company, with a mailing address of 8742 Lucent Blvd., Suite
225, Highlands Ranch, CO 80129, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB or the OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U>&nbsp;</FONT><U>Exercise</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made,
in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the
Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the
&ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as
reasonably practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this
Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than
the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.00</B>, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement
registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant
may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise
is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Mechanics of Exercise</U>. </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause
the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and
otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the
Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period, in each case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case following the delivery
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in">Notwithstanding the
foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Day immediately
prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company
agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the
Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part,
the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares,
deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this
Warrant, which new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder
the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such
exercise.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition
to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if
after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of
the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to
timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase
upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the
Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes
and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names
as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner
which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be [4.99%/9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.&nbsp;</U></FONT><U>Certain
Adjustments</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding:
(i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity
equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued
by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii)
combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues
by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall
be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after
such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above,
if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled
to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that the Holder's right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent)
and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation). </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company,
directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person,
(ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or
indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the
outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from
the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised
portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction
is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to
receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes
Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental
Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which may be the Company
following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this
Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the
day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility
or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day
annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction,
(C) the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d), (D) a remaining option
time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt,
the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient
authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the
Initial Exercise Date. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the
nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued
and outstanding.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Holder</U>. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other
distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption
of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries)
is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its
last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for
securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided
that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4.</U>&nbsp;</FONT><U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation
hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants
are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may
be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the
initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by
the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or
any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.&nbsp;</U></FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle
the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in
Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event
shall the Company be required to net cash settle an exercise of this Warrant. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action
or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may
be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Authorized Shares</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">Except and to the extent
as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without
regard to the principles of conflicts of law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal
proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought
against the Company or the Holder or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant,
the Holder each hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue
for such proceeding. The Company and, by accepting this Warrant, the Holder each hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to it at the address in effect for notices to it under this Warrant and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If the Company or the Holder shall commence an action, suit
or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by
the other party for their reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of
this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state
and federal securities laws.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right
hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies,
notwithstanding the fact that the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at 12300 Grant Street, Thornton, CO 80241, Attention: Jin Jo, Chief Financial  Officer,
email address: jjo@ascentsolar.com, or such other email address or address as the Company may specify for such purposes by
notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in
writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to the Holder at
the e-mail address or address of the Holder appearing on the books of the Company. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is
delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the
next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set
forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the
second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon
actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided by the Company
hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by
the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall
give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary
damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights
and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company
and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under
applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>ASCENT
    SOLAR TECHNOLOGIES, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 2.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">To:</FONT><B>ASCENT
SOLAR TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">[
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">[
] the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set
forth in subsection 2(c).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#9;<B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the
foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/115% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Name:</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/115% Times New Roman, Times, Serif; text-align: justify">____________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Address:</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">____________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Email Address:</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s
Signature: ____________________________</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s
Address: ____________________________</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; text-align: center">B-1</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4x2.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">Exhibit 4.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ASCENT
SOLAR TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: _______</TD>
  <TD STYLE="text-align: right; width: 50%">Issue Date: ______, 2025</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: right">Initial Exercise Date: ______, 2025</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination
Date</U>&rdquo;), to subscribe for and purchase from Ascent Solar Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock.
The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 1.</U></FONT>&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (the &ldquo;<U>OTCQB</U>&rdquo;)
or the OTCQX Best Market (the &ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on the OTCQB or the OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on the OTCQB or the OTCQX and if prices for the Common Stock are then reported on The Pink Open Market operated by the OTC
Markets, Inc. (the &ldquo;<U>Pink Market</U>&rdquo;) (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common
Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Registration Statement</U>&rdquo;
means the effective registration statement on Form S-1 (File No. 333-288300) filed with the Commission, including all information, documents
and exhibits filed with or incorporated by reference into such registration statement, as amended from time to time, which registers the
sale of the Warrants and the Warrant Shares, among others, to the purchasers, and includes any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo;
means the subsidiaries of the Company set forth on <U>Exhibit 21.1</U> to the Registration Statement and shall, where applicable, also
include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Trading Market on which the Common Stock is then listed is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Computershare Investor Services, LLC, the current transfer agent of the Company, with a mailing address of 8742 Lucent Blvd., Suite
225, Highlands Ranch, CO 80129, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB or the OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><U></U></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U></FONT><U>Exercise</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made,
in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the
Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the
&ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as
reasonably practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this
Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than
the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise
price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional
consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person
to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid
aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been
exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001,
subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by
means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient
obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise
is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Mechanics of Exercise</U>. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if
the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of
the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and
otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the
Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period, in each case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery
to the Company of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a
Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as
a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant
Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to
4:00 p.m. (New York City time) on the Trading Day immediately prior to the Initial Exercise Date, which may be delivered at any time after
the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m.
(New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes
hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant
Share Delivery Date.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part,
the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares,
deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this
Warrant, which new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder
the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such
exercise.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition
to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if
after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of
the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to
timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase
upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the
Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes
and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names
as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner
which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be [4.99%/9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><U></U></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.</U></FONT>&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding:
(i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity
equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued
by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii)
combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues
by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall
be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after
such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above,
if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled
to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that the Holder's right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent)
and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation). </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company,
directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person,
(ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or
indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the
outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in
accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the
Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other
Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had
been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section
3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or
(ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the
nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued
and outstanding.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Holder</U>. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other
distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption
of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries)
is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its
last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for
securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided
that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4.</U></FONT>&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation
hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants
are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may
be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the
initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by
the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or
any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.</U></FONT>&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle
the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in
Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event
shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action
or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may
be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Authorized Shares</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">Except and to the extent
as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without
regard to the principles of conflicts of law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal
proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought
against the Company or the Holder or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant,
the Holder each hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue
for such proceeding. The Company and, by accepting this Warrant, the Holder each hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to it at the address in effect for notices to it under this Warrant and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If the Company or the Holder shall commence an action, suit
or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by
the other party for their reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of
this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state
and federal securities laws.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right
hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies.
Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply
with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those
of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
powers or remedies hereunder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at 12300 Grant Street, Thornton, CO 80241, Attention: Jin Jo, Chief Financial Officer,
email address: jjo@ascentsolar.com,
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or
other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail,
or sent by a nationally recognized overnight courier service addressed to the Holder at the e-mail address or address of the Holder
appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective
on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set
forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a
Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of
mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such
notice is required to be given. To the extent that any notice provided by the Company hereunder constitutes, or contains, material,
non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by
the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall
give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary
damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights
and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company
and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under
applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>Ascent Solar Technologies, Inc.
    </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 2.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase">To: <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ascent
Solar Technologies, Inc. </B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the
terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in">[ ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in; text-align: justify; text-indent: 0in">[ ] the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified
below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#9;<B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the
foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/115% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Name:</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt/115% Times New Roman, Times, Serif; text-align: justify">_________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Address:</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">__________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Email Address:</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s
Signature: ___________________</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s
Address: ____________________</FONT></TD>
    <TD STYLE="font: 12pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">B-1</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ex4x3.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">Exhibit 4.3</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: center"><FONT STYLE="text-transform: uppercase"><B>ASCENT SOLAR TECHNOLOGIES,
INC.</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 3.5in; text-align: left; text-indent: 1.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom; text-align: center">
  <TH STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: ______</FONT></TH>
  <TH STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: _______, 2025</FONT></TH></TR>
<TR STYLE="vertical-align: bottom; text-align: center">
  <TH STYLE="text-align: left">&nbsp;</TH>
  <TH STYLE="text-align: right">Initial Exercise Date: _______, 2025</TH></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 3.5in; text-align: left; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">THIS PLACEMENT AGENT
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or
prior to 5:00 p.m. (New York City time) on ________, <SUP>2</SUP> (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to
subscribe for and purchase from Ascent Solar Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to
______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The
purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
This Warrant is being issued pursuant to that certain Engagement Agreement by and between the Company and H.C. Wainwright &amp; Co.,
LLC, dated as of June 17, 2025, as amended on June 23, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 1.</U>&nbsp;</FONT><U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (the &ldquo;<U>OTCQB</U>&rdquo;)
or the OTCQX Best Market (the &ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock
for such date (or the nearest preceding date) on the OTCQB or the OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on the OTCQB or the OTCQX and if prices for the Common Stock are then reported on The Pink Open Market operated by the OTC
Markets, Inc. (the &ldquo;<U>Pink Market</U>&rdquo;) (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common
Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the </FONT>Warrants
<FONT STYLE="background-color: white">then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><SUP>2</SUP>
The date that is the [five (5)] year anniversary of the commencement of sales pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Registration Statement</U>&rdquo;
means the effective registration statement on Form S-1 (File No. 333--288300) filed with the Commission, including all information, documents
and exhibits filed with or incorporated by reference into such registration statement, as amended from time to time, which registers the
sale of the Warrants and the Warrant Shares, among others, to the purchasers, and includes any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo; means
the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo;
means the subsidiaries of the Company set forth on <U>Exhibit 21.1</U> to the Registration Statement and shall, where applicable, also
include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Trading Market on which the Common Stock is then listed is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 6pt; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Computershare Investor Services, LLC, the current transfer agent of the Company, with a mailing address of 8742 Lucent Blvd., Suite
225, Highlands Ranch, CO 80129, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB or the OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U>&nbsp;</FONT><U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made,
in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the
Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the
&ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as
reasonably practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this
Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than
the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.50</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 6pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement
registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant
may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise
is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The
Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account
of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at
Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective
registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant
is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day
and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery to the Company of the
Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
(other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading
Days comprising the Standard Settlement Period, in each case following the delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0in">Notwithstanding the
foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Day immediately
prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company
agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the
Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part,
the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares,
deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this
Warrant, which new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder
the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such
exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase
upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal
to such fraction multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the
Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes
and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names
as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner
which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be [4.99%/9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.&nbsp;</U></FONT><U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding:
(i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity
equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued
by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii)
combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues
by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall
be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after
such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above,
if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise, other than cash (including, without limitation, any distribution of stock or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar
transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder
shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that the Holder's right to participate
in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company,
directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person,
(ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or
indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the
outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from
the Holder by paying to the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised
portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction
is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to
receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes
Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental
Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which may be the Company
following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this
Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the
day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility
or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day
annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction,
(C) the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d), (D) a remaining option
time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to
each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and
such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt,
the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient
authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the
Initial Exercise Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the
nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued
and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Holder</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other
distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption
of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries)
is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its
last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for
securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided
that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4.&nbsp;</U></FONT><U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation
hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants
are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may
be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the
initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by
the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or
any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.&nbsp;</U></FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle
the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in
Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event
shall the Company be required to net cash settle an exercise of this Warrant. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action
or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may
be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Authorized Shares</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: 0.5in">Except and to the extent
as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: 0.5in">Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without
regard to the principles of conflicts of law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal
proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought
against the Company or the Holder or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant,
the Holder each hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue
for such proceeding. The Company and, by accepting this Warrant, the Holder each hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to it at the address in effect for notices to it under this Warrant and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If the Company or the Holder shall commence an action, suit
or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by
the other party for their reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of
this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state
and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right
hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies,
notwithstanding the fact that the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the holders
hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a
nationally recognized overnight courier service, addressed to the Company, at 12300 Grant Street, Thornton, CO 80241, Attention: Jin Jo,
Chief Financial Officer, email address: jjo@ascentsolar.com, or such other email address or address as the Company may specify for such
purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall
be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to the Holder
at the e-mail address or address of the Holder appearing on the books of the Company. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered
via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading
Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom
such notice is required to be given. To the extent that any notice provided by the Company hereunder constitutes, or contains, material,
non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by
the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall
give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary
damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights
and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company
and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under
applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Page Follows)<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="text-transform: uppercase"><B>ASCENT
    SOLAR TECHNOLOGIES, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 2.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">To:</FONT><B>ASCENT
SOLAR TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the
terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0in">[ ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 1.5in; text-align: justify; text-indent: 0in">[ ] the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified
below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 15; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#9;<B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the
foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt/115% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Name:</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt/115% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Address:</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif;  text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif;  text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif;  text-align: justify">Email Address:</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif;  text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif;  text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt/115% Times New Roman, Times, Serif;  text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: bottom; font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; line-height: 115%"></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; line-height: 115%">Dated: _______________ __, ______</FONT></P></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s
Signature:_______________________________</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">Holder&rsquo;s
Address:_______________________________</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 30pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif;  text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 9pt">B-1</FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>






</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10x1.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">Exhibit 10.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><B>SECURITIES
PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Securities
Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of June 27, 2025, between Ascent Solar Technologies, Inc., a
Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each,
including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the
terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined
below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from
the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>ARTICLE I.</B><FONT STYLE="font-size: 10pt"><BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT> <FONT STYLE="font-size: 10pt"><U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes
of this Agreement, the following terms have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(mm).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of
Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares and the Warrants pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Shares and the Warrants, in each case, have been satisfied or waived, but in no event later than the first
(1<SUP>st</SUP>) Trading Day following the date hereof (or the second (2nd) Trading Day following the date hereof if this Agreement is
signed on a day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading
Day).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively the Common Stock purchase warrants delivered to the
Purchasers at the Closing in accordance with Section 2.2(a) hereof, which such Common Warrants shall be exercisable immediately and have
a term of exercise that expires on the five (5) year anniversary following the initial issuance date, in the form of <U>Exhibit B</U>
attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Carroll Legal LLC, with offices located at 1449 Wynkoop Street, Suite 507, Denver, CO 80202.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) warrants
to the Placement Agent in connection with the transactions pursuant to this Agreement and any securities upon exercise of the warrants
to the Placement Agent, if applicable, and/or securities upon the exercise or exchange of or conversion of any Securities issued hereunder
and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date
of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such
securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock
splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or
to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">&#8239;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(mm).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GDPR</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreements</U>&rdquo;
means, collectively, the Lock-Up Agreements, dated as of the date hereof, by and among the Company and the directors and officers of the
Company, in the form of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $2.00, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date, provided
that the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.0001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Personal
Data</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means H.C. Wainwright &amp; Co., LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Policies</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means any preliminary prospectus included in the Registration Statement, as originally filed or as part of any amendment
thereto, or filed with the Commission pursuant to Rule 424(a) of the rules and regulations of the Commission under the Securities Act,
including all information, documents and exhibits filed with or incorporated by reference into such preliminary prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pricing
Prospectus</U>&rdquo; means (i) the Preliminary Prospectus relating to the Securities that was included in the Registration Statement
immediately prior to 2:00 p.m. (New York City time) on the date hereof and (ii) any free writing prospectus (as defined in the
Securities Act) identified on <U>Schedule A</U> hereto, taken together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Privacy
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed pursuant to the Registration Statement, including all information, documents and exhibits filed with
or incorporated by reference into such final prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-1 (File No. 333--288300) filed with the Commission, including all
information, documents and exhibits filed with or incorporated by reference into such registration statement, as amended from time to
time, which registers the issuance and sale of the Securities to the Purchasers, and includes any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 462(b)
Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities, which was
filed with the Commission on or prior to the time at which sales of the Shares and the Warrants were confirmed and became automatically
effective pursuant to Rule 462(b) promulgated by the Commission pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Sanctions</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(kk).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Shares, the Pre-Funded Warrants (if applicable)
and the Common Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and
next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (excluding for the
avoidance of doubt, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid
as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Lock-Up Agreements, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Investor Services, LLC, the current transfer agent of the Company, with a mailing address of 8742
Lucent Blvd., Suite 225, Highlands Ranch, CO 80129, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><FONT STYLE="font-size: 10pt"><BR>
PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">2.1 <FONT STYLE="font-size: 10pt"><U>Closing</U>.
On</FONT>&nbsp; <FONT STYLE="font-size: 10pt">the Closing Date, upon the terms and subject to the conditions set forth herein, the Company
agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of $2,000,000 of Shares and Common Warrants;
provided, however, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially
own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares, such Purchaser
may elect, by so indicating such election prior to their issuance, to purchase Pre-Funded Warrants in lieu of Shares in such manner to
result in the same aggregate purchase price being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, with respect to each Purchaser, at the election of such Purchaser at Closing, 9.99%) of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of the Shares on the Closing Date. In each case, the election
to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser&rsquo;s Subscription Amount as set forth on the
signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;)
settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares and a Common Warrant (and,
if applicable, a Pre-Funded Warrant) as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other
items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2
and 2.3, the Closing shall take place remotely by electronic transmission of the Closing documentation. Unless otherwise directed by
the Placement Agent, settlement of the Shares shall occur via DVP (i.e., on the Closing Date, the Company shall issue the Shares registered
in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified
by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable
Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding
anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable
Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser
sells to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement
Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement
Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such
Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder; and provided further that
the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to
whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and that any such
decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to effect any such
sale, if any. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">Notwithstanding
the foregoing, with respect to any Notice(s) of Exercise (as defined in the Warrants) delivered on or prior to 4:00 p.m. (New York City
time) on the Trading Day immediately prior to the Closing Date, which may be delivered at any time after the time of execution of this
Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Closing
Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Warrants) for purposes hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to
be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">a legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in form and
substance reasonably acceptable to the Placement Agent and Purchasers; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company
letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">subject to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing
the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system Shares
equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price (minus the number of shares of Common Stock
issuable upon exercise of such Purchaser&rsquo;s Pre-Funded Warrants, if applicable), registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of
Common Stock equal to 100% of such Purchaser&rsquo;s Shares and Pre-Funded Warrant Shares, if applicable, with an exercise price equal
to $2.00 per share, subject to adjustment therein; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">if applicable, for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s
Subscription Amount applicable to Pre-Funded Warrants divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal
to $0.0001 per share, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">on the date hereof, the duly executed Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(viii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">the Prospectus (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">such Purchaser&rsquo;s Subscription Amount (minus, if applicable, a Purchaser&rsquo;s aggregate exercise
price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash), which shall
be made available for DVP settlement with the Company or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">the accuracy in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of
the Purchasers contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate
in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in
all respects) as of such date); </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">all obligations, covenants and agreements of each Purchaser required to be performed at or prior
to the Closing Date shall have been performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">The respective obligations of the Purchasers hereunder in connection with the Closing are subject
to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">the accuracy in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of
the Company contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate
in all material respects (or to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">all obligations, covenants and agreements of the Company required to be performed at or prior to
the Closing Date shall have been performed; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">there shall have been no Material Adverse Effect with respect to the Company since the date hereof;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended
by the Commission or the Company&rsquo;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally
as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities
whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United
States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case,
in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>ARTICLE III.</B><FONT STYLE="font-size: 10pt"><BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules,
which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of
the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations
and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on
<U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary
free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are
fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly
incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or
organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently
conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or
articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified
to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or
condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii),
a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing
or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to
enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction
Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all
necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s
stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have
been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and
the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions
contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s
certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a
default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon
any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution
or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility,
debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Pricing Prospectus
and the Prospectus, (iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities
and the listing of the Shares and the Warrant Shares for trading thereon in the time and manner required thereby,  and (iv) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Issuance of the Securities; Registration</U>. The Shares and the Warrants are duly authorized and, when issued and paid
for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Warrants, when paid for and issued in accordance with this Agreement, will constitute valid and
binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general
principles of equity. The Pre-Funded Warrant Shares are duly authorized, and when issued in accordance with the terms of the Pre-Funded
Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Common Warrant
Shares are duly authorized, and when issued in accordance with the terms of the Common Warrants, will be validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the
maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the
Registration Statement in conformity with the requirements of the Securities Act, which became effective on&nbsp;June 27, 2025, including
the Pricing Prospectus and the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement.
The Company was at the time of the filing of the Registration Statement eligible to use Form S-1. The Registration Statement is effective
under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing
the use of the Pricing Prospectus or the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted
or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission,
shall file the Prospectus with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto
became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed
and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading;
and the Pricing Prospectus and the Prospectus and any amendments or supplements thereto, at the time the Pricing Prospectus or the Prospectus,
as applicable, or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects
to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on
<U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of
record, by Affiliates of the Company as of the date hereof. Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued
any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee
stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s
employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of
the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase
and sale of the Securities and as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any
Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to
issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities
will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers).
There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares
was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements
and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a)
or 15(d) thereof, for the two (2) years preceding the date hereof (or such shorter period as the Company was required by law or regulation
to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together
with the Pricing Prospectus and the Prospectus, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely
basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act
and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments. The Company has never been an issuer subject to Rule 144(i) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest
audited financial statements included within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event,
occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has
not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course
of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements
pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the
Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or
made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to
any officer, director or Affiliate, except pursuant to existing Company equity compensation plans. The Company does not have pending before
the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement
or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or
is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties,
operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the
time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that
this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Litigation</U>. There is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). There is no Action that adversely affects or challenges the legality, validity or enforceability
of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected
to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the
subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission
involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the
Securities Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent
with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of
the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with
the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and
the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive
officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any
restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company
or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation
of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company
or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in
violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any
of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or
order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or
regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental
protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could
not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Environmental Laws</U>.&#9;The Company and its Subsidiaries (i) are in compliance with all federal,
state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water,
groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of
chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;)
into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental
Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct
their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in
each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations
and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses
as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material
Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple
to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business
of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value
of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease
by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries
are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents,
patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and
other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as
described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual
Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any
of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest
audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude
it from having valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or
will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and
the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate
Subscription Amount. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports or on <U>Schedule
3.1(r)</U>, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees
of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as
employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to
or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to
or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which
any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner,
in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for
expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option
plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance
with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof and as
of the Closing Date, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of
the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure
that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers
have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company
presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness
of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its
Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting
of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Certain Fees</U>. Except as set forth in the Pricing Prospectus or the Prospectus, no brokerage
or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.
The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for
fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after
receipt of payment for the Securities, will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the
Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment
company&rdquo; subject to registration under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Registration Rights</U>. Except as set forth in the SEC Reports, no Person has any right to cause
the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b)
or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect
of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission
is contemplating terminating such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding
the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that
the Company is not in compliance with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports,
the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another
established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established
clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all
necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation
(or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result
of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without
limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated
by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers
or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which
is not otherwise disclosed in the Pricing Prospectus or the Prospectus. The Company understands and confirms that the Purchasers will
rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on
behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated
hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under
which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this
Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made,
not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and
warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder
approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date,
after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value
of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts
and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably
small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account
the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital
availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to
liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or
in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability
to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The
Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under
the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as
of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any
Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed
money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for
deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess
of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with
respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably
be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal,
state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which
it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any
Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of
the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly,
used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity,
(ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties
or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any
person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any
provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Accountants</U>. The Company&rsquo;s independent registered public accounting firm is set forth
on <U>Schedule 3.1(dd)</U> of the Disclosure Schedules. To the knowledge and belief of the Company, such accounting firm (i) is a registered
public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to
be included in the Company&rsquo;s Annual Report for the fiscal year ending December 31, 2025.&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT> <FONT STYLE="font-size: 10pt"><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges
and agrees that each of the Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction
Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor
or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby
and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents
and the transactions contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further
represents to each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been
based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; ">Acknowledgment Regarding Purchaser&rsquo;s
Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.13
hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor
has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock, and (iv) each Purchaser shall
not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction.
The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging
activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that
the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any)
could reduce the value of the existing stockholders' equity interests in the Company at and after the time that the hedging activities
are being conducted.&nbsp; The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the
Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Regulation M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on
its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the
price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid
any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for
soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid
to the Placement Agent in connection with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>[Reserved].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock
option plan was granted (i) in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least
equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable
law. No stock option granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and
there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the
grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries
or their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Cybersecurity</U>.&nbsp; (i) (x) There has been no security breach or other compromise of or relating
to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data
(including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of
it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not
been notified of, and have no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable
laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such
IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; letter-spacing: -0.15pt"><U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary
nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject
to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; letter-spacing: -0.15pt"><U>U.S. Real Property Holding Corporation</U>. The Company is not and has
never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended,
and the Company shall so certify upon Purchaser&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(mm)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; letter-spacing: -0.15pt"><U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries
or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the
Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries
or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities
or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the
Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or
policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; letter-spacing: -0.15pt"><U>Money Laundering</U>. The operations of the Company and its Subsidiaries
are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency
and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations
thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending
or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times
were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including, without
limitation and to the extent applicable to the Company and the Subsidiaries, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;)
(EU 2016/679) (collectively, &ldquo;<U>Privacy Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and
take appropriate steps reasonably designed to ensure compliance with their policies and procedures relating to data privacy and security
and the collection, storage, use, disclosure, handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;);
(iii) the Company provides accurate notice of its applicable Policies to its customers, employees, third party vendors and representatives
as required by Privacy Laws; and (iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy
practices relating to its subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices,
as required by Privacy Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number,
email address, photograph, social security number, bank information, or customer or account number; (ii) &ldquo;personal data&rdquo; as
defined by GDPR; and (iii) any other piece of information that allows the identification of such natural person, or his or her family,
or permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. None
of such disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy
Laws and the Company does not have any reason to believe that the execution, delivery and performance of the Transaction Documents will
result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries, (i) has, to the knowledge of the Company,
received written notice of any actual or potential liability of the Company or the Subsidiaries under, or actual or potential violation
by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently conducting or paying for, in whole or in part, any investigation,
remediation or other corrective action pursuant to any regulatory request or demand pursuant to any Privacy Law; or (iii) is a party to
any order, decree, or agreement by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation
or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other
Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific
date therein, in which case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated
or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right,
corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated
by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by
all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each
Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance
with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for
its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution
of such Securities (this representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the
Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the
Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of
the date hereof it is, and on each date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act or (ii) a &ldquo;qualified
institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives,
has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks
of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able
to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review
the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity
to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms
and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about
the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it
to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire
without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.&nbsp;
Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser
with any information or advice with respect to the Securities nor is such information or advice necessary or desired.&nbsp; Neither the
Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement
Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided
to it.&nbsp; In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates
has acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated
hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly
or indirectly executed any purchases or sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing
as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the
Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof.
Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only
apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including,
without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has
maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of
this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">The Company acknowledges
and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely
on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>ARTICLE IV.</B><FONT STYLE="font-size: 10pt"><BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Shares and Warrant Shares</U>. The Shares shall be issued free of legends. If all or any portion
of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Warrant Shares
or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall be issued free of
all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering
the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Warrant Shares,
the Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective and
thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale or resale
of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser
to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use best efforts
to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Warrant Shares effective
during the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Furnishing of Information.</U> Until the earlier of the time that (i) no Purchaser owns Securities
and (ii) the Common Warrants have expired, the Company covenants to timely file (or obtain extensions in respect thereof and file within
the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if
the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of
the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to
the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue
a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including
the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance
of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information
delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction
Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality
or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of
the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The
Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated
hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without
the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser,
with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent
of the Company, any other Person, that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition,
business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in
effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement,
by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions
contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither
it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented
in writing to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company
understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the
Company. To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or
Affiliates delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants
and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any
of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject
to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder
as set forth in the Pricing Prospectus and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation, or (d) in violation of FCPA or
OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company
will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other
Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title),
each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and
the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role
of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser
Party&rdquo;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including
all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such
Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser
Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such
Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based
upon a material breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any
agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state
or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence
or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant
to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, the Company shall have the right to assume
the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the
right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized
by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel
or (iii) in such action there is, in the reasonable opinion of counsel a material conflict on any material issue between the position
of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement
by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed;
or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach
of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction
Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in
addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company
may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company
shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for
the purpose of enabling the Company to issue the Shares pursuant to this Agreement and the Warrant Shares pursuant to any exercise of
the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing
or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company
shall apply to list or quote all of the Shares and the Warrant Shares on such Trading Market and promptly secure the listing of all of
the Shares and the Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock
traded on any other Trading Market, it will then include in such application all of the Shares and the Warrant Shares, and will take such
other action as is necessary to cause all of the Shares and the Warrant Shares to be listed or quoted on such other Trading Market as
promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock
on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws
or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the
Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the
Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Subsequent Equity Sales</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">From the date hereof until ninety (90) days after the Closing Date, neither the Company nor any Subsidiary
shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common
Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, other than (a) the Prospectus, (b) a
registration statement on Form S-8 in connection with any employee benefit plan, or (c) any amendment or supplement to any existing registration
statement pursuant to an &ldquo;at-the-market&rdquo; facility with the Placement Agent as sales agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">From the date hereof until the one (1) year anniversary of the Closing Date, the Company shall be
prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock
or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo;
means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or
exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock
at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is
subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified
or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into,
or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market&rdquo;
facility, whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement
have actually been issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that, following
the restrictive period set forth in Section 4.11(a) above, the entry into and/or issuance of shares of Common Stock in an &ldquo;at-the-market&rdquo;
facility with the Placement Agent as sales agent shall not be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain
injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt">Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance,
except that no Variable Rate Transaction shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Equal Treatment of Purchasers</U>. No consideration (including any modification of this Agreement)
shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same
consideration is also offered to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the
Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the
other Purchasers, covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute
any purchases or sales, including Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution
of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4.<FONT STYLE="color: windowtext">&nbsp; </FONT>Each Purchaser, severally and not
jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed
by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of
the existence and terms of this transaction and the information included in the Disclosure Schedules (other than as disclosed to its legal
and other representatives).&nbsp; N<FONT STYLE="color: windowtext">otwithstanding the foregoing and notwithstanding anything contained
in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty
or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no
Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release as described in Section
4.4.&nbsp; </FONT>Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; color: windowtext"><U>Capital Changes</U>. </FONT><FONT STYLE="font-size: 10pt">Until the one year
anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock
without the prior written consent of the Purchasers holding a majority in interest of the Shares other than a reverse stock split that
is required, in the good faith determination of the Board of Directors, to maintain the listing of the Common Stock on the Trading Market<FONT STYLE="color: windowtext">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt; color: windowtext"><U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants
set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other
information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences,
no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall
deliver the Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">4.16 <FONT STYLE="font-size: 10pt; color: windowtext"><U>Lock-Up
Agreements</U>.</FONT> <FONT STYLE="font-size: 10pt">The Company shall not amend, modify, waive or terminate any provision of any of the
Lock-Up Agreements except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance
with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its
best efforts to seek specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><FONT STYLE="font-size: 10pt"><BR>
MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Termination</U>.&nbsp; This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s
obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written
notice to the other parties, if the Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the
date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for any breach by any
other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary,
each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred
by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all
Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the
Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery
of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto,
the Pricing Prospectus and the Prospectus, contain the entire understanding of the parties with respect to the subject matter hereof and
thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge
have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to
be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if
such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice
or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that
is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached
hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented
or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least
50.1% in interest of the Shares and the Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing,
the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought,
provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers),
the consent of at least 50.1% in interest of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required.
No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment
or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the
parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without
the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement
to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound,
with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of
the representations and warranties of the Company in Section 3.1, the covenants of the Company in Article 4 and the representations and
warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any
of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it
is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue
for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents,
then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed
by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Survival</U>. The representations and warranties contained herein shall survive the Closing and
the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and
delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature
is delivered by e-mail delivery (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method,
such signature shall be deemed to have been duly and validly delivered and shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by
a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the
parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially
the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the
intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and
without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election,
demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein
provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any
relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>,
that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common
Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid
to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s
Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated,
lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof
(in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such
circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted
by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such
obligation the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser
pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds
of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside,
recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued
in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser
under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible
in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained
herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute
the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.
Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out
of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an
additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review
and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel
have chosen to communicate with the Company through the legal counsel of the Placement Agent. The legal counsel of the Placement Agent
does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with
the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any
of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and
among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages
or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid
partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which
such partial liquidated damages or other amounts are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Saturdays, Sundays, Holidays, etc.</U>&#9;If the last or appointed day for the taking of any action
or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may
be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">5.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed
and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities
are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject
to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock
that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.21</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><FONT STYLE="font-size: 10pt"><B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT
BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW,
HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>(Signature Pages Follow)</I></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#9;<FONT STYLE="font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 63%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase"><B>ASCENT SOLAR TECHNOLOGIES,
    INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="width: 37%; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; ">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">With a copy to (which shall not constitute notice):</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">E-Mail:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">ASTI</FONT>
SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date
first indicated above.</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_________________________________</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt/200% Times New Roman, Times, Serif; margin: 0; text-align: justify">Email Address of Authorized Signatory: _________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Address for Delivery of Warrants to Purchaser (if not same as address for
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pre-Funded Warrant Shares: ___________ Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">o</FONT>
4.99% or <FONT STYLE="font-family: Wingdings">o</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Common Warrant Shares: _____________ Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">o</FONT>
4.99% or <FONT STYLE="font-family: Wingdings">o</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 24pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Wingdings">o</FONT> Notwithstanding
anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities
set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities
to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur by the first
(1<SUP>st</SUP>) Trading Day following the date of this Agreement (or the second (2nd) Trading Day following the date hereof if this Agreement
is signed on a day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading
Day), and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required
delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall
no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver
such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99x1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 18pt"><FONT STYLE="font-size: 12pt"><B>Ascent Solar Technologies,
Inc. Announces Pricing of $2.0 Million Public Offering</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt">THORNTON, Colo., June 27, 2025 (GLOBE NEWSWIRE) -- Ascent Solar
Technologies, Inc. (NASDAQ: ASTI) (&ldquo;Ascent&rdquo; or the &ldquo;Company&rdquo;), the leading U.S. innovator in the design and manufacture
of featherweight, flexible, and durable CIGS thin-film photovoltaic (PV) solutions, today announced the pricing of a public offering of
an aggregate of 1,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,000,000
shares of common stock (the &ldquo;Warrants&rdquo;), at a combined public offering price of $2.00 per share (or per pre-funded warrants
in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $2.00 per share, will be exercisable immediately
upon issuance, and will expire on the five-year anniversary of the initial issuance date. The closing of the offering is expected to occur
on or about June 30, 2025, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt">H.C. Wainwright &amp; Co. is acting as the exclusive placement
agent for the offering.</P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt">The aggregate gross proceeds to the Company from the offering
are expected to be $2.0 million before deducting the placement agent's fees and other offering expenses payable by the Company. The Company
intends to use the net proceeds from this offering for working capital, product development activities, general and administrative expenses
and other general corporate purposes.</P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt">The securities described above are being offered pursuant to
a registration statement on Form S-1 (File No. 333-288300), which was declared effective by the Securities and Exchange Commission (the
&quot;SEC&quot;) on June 27, 2025. The offering is being made only by means of a prospectus forming part of the effective registration
statement relating to the offering. A preliminary prospectus relating to the offering has been filed with the SEC and is available on
the SEC's website at http://www.sec.gov and a final prospectus relating to the offering will be filed with the SEC. Electronic copies
of the final prospectus, when available, may be obtained on the SEC's website at http://www.sec.gov and may also be obtained, when available,
by contacting H.C. Wainwright &amp; Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at
placements@hcwco.com.</P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt">This press release shall not constitute an offer to sell or
a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state
or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt"><B>About Ascent Solar Technologies, Inc.</B></P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt">Backed by 40 years of R&amp;D, 15 years of manufacturing experience,
numerous awards, and a comprehensive IP and patent portfolio, Ascent Solar Technologies, Inc. is a leading provider of innovative, high-performance,
flexible thin-film solar panels for use in environments where mass, performance, reliability, and resilience matter. Ascent&rsquo;s photovoltaic
(PV) modules have been deployed on space missions, multiple airborne vehicles, agrivoltaic installations, in industrial/commercial construction
as well as an extensive range of consumer goods, revolutionizing the use cases and environments for solar power. Ascent Solar&rsquo;s
research and development center and 5-MW nameplate production facility is in Thornton, Colorado. To learn more, visit&nbsp;https://www.ascentsolar.com.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Forward-Looking Statements</B></P>

<P STYLE="text-align: justify; font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">Statements in this press release that are not statements of
historical or current fact constitute &quot;forward-looking statements&quot; including statements about the completion of the offering,
the satisfaction of customary closing conditions related to the offering and the anticipated use of proceeds therefrom. Such forward-looking
statements involve known and unknown risks, uncertainties and other unknown factors that could cause the company's actual operating results
to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements,
including market and other conditions. We have based these forward-looking statements on our current assumptions, expectations, and projections
about future events. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements
that contain terms such as &quot;will,&quot; &quot;believes,&quot; &quot;belief,&quot; &quot;expects,&quot; &quot;expect,&quot; &quot;intends,&quot;
&quot;intend,&quot; &quot;anticipate,&quot; &quot;anticipates,&quot; &quot;plans,&quot; &quot;plan,&quot; to be uncertain and forward-looking.
No information in this press release should be construed as any indication whatsoever of our future revenues, stock price, or results
of operations. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described
from time to time in the company's filings with the Securities and Exchange Commission including those discussed under the heading &quot;Risk
Factors&quot; in our most recently filed reports on Forms 10-K and 10-Q.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt"><B>Media Contact</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0pt">Spencer Herrmann</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0pt">FischTank PR</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">ascent@fischtankpr.com</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>asti-20250627.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aAps7xRiXgen8uEYHMsSauJ6bPtx517CZkhvmh1bQl6rywpXgGGjSfwRjTmEaEE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ASTI="http://ascentsolar.com/20250627" elementFormDefault="qualified" targetNamespace="http://ascentsolar.com/20250627">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://ascentsolar.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="asti-20250627_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="asti-20250627_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>asti-20250627_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>asti-20250627_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ascentsolar.com/role/Cover" xlink:href="asti-20250627.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ascentsolar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 27,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ASCENT SOLAR
TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001350102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-3672603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12300 Grant Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Thornton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">872-5000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASTI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="asti_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ascentsolar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asti-20250627.xsd</File>
    <File>asti-20250627_lab.xml</File>
    <File>asti-20250627_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="asti_8k.htm">asti_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "asti_8k.htm": {
   "nsprefix": "ASTI",
   "nsuri": "http://ascentsolar.com/20250627",
   "dts": {
    "schema": {
     "local": [
      "asti-20250627.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "asti-20250627_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asti-20250627_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "asti_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://ascentsolar.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asti_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asti_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ascentsolar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001079973-25-001080-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001079973-25-001080-xbrl.zip
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M5,V@TAA\%;PSR/'MA0$-,&XR=$0$A-X F] -ASP2Y:$?4!&,:M&>SL_20Q9
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MR.Z<%[G@Z=.)R*WRW8E7W[6[?[[_<\\;/<J=B/[$VY)]'^U; 'T"8\<6G<T
M9^9FW8U>SW,W&>1*G=^F+B/&;IG@*O\?/="BS5C,] +>! *C@7(GP!91:34S
MC.;#$=4;50-&U_,QGK-D!%\)[;^AX-7W_"B%=J*#QU('1;%VR49VB+8?89V<
MKX(?AJ?&GWHW>/=^L'9$T_7%0C&[=JESU.^BA^^??SRZU*Y.NK^>G7\\?P^Y
M49GTSKK5I3J7.)\?5BN>$]&MDWL0!)< ^K$@YKQ&0Q+ZS,2"TR(V*$H4$O#P
MX,:"[9?',V/>$1TX#.8X#G#.Q#9["1P5?O:I9:G/6=R,U;C=V58T1C+J;Y9@
M@H5+).N<P\A2R]RR(+)-ZBB*!EX4>9,8J+'WYI%F6B\PT]V,F?9<T"E?JE4_
M H?<%2W9KF<56.T4\M!PQ-Q[<[ANX,!F.'8+(N8'WBTJST+D,!;->BFN$$N9
M0^\@!CW$G"-KI0 BSX^YWRI@OM*J1X)K-#<ES'<989[:#@.J!RS(EYS5_?+7
MI]:7&^N/]OK^MK$HF&1=[#OIE8;1UMNO4PS/9E;MC"2NZ'U/MMM,KJ[+Q')<
MGYV?W[0_WM^-UQ=+3K^T (E2QZA7&CN[QDZ]\4 AP1]!D>,:> &$H@K(";CK
M@-<C.KC*T'-LZX 4L?_Q+-_B!H]UCA>-64"^0MT06K8H@"#RV&GGL/UH#7ND
M6CV*Z,(%5E#<]283.\1=88(61H3X_AFT]:J7U7Z5G$Q\QYN!.+.*2LZ\ZG:N
M M9X['YR,O;#Y G+_5AI07@2]L[&(DPSX]>.+"M@82C_^@CYIUZ0VO]^^>'\
M0W-X_-%<WZ>U%GU:#@*ECFXTZG7R'M-.TH\"QJ(U@X^*SSMO\C@UI!/;F>VO
M$N\"5Y5.Y?K3QPIX(T+=R1-J%_YY'EQY=VZ^2#^=?/GD3':.?G7T]46Z4RC2
M9/E2YVKL!6[DN05B+"_T/XP\@GC$. \N(,6$Z%"0S9Y_:GT>W(WI)Z.Y/E6[
MA53-X5#J=,\+B"*KE/-ADE]725=6"I*@"P_R=N<OVR\N$':_-$YVK=#\6W\"
M2_<*69K!H-39JQM-_?%YS//;W9;$%[,3/P#IVSYU"+MGYC2R;[%<AG#'PNU%
M]_"RDA?K;P%#"7+TD7'W ?$NCKO_F/!J[.:&5_F=[6(RPSMLK;3_+PXXS1V
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M._#& Q56M97M,>:K[K:&70:'/X7TI#"@/44*K\WY7.5R@C?< '.0%)3T ")
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MRYL?V^Z'K_"_A\&J&$T?!08T0/XE6)\#$3IMCE.8')Q5LWU_6O2M"M"D0,C
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M4#=;4O.-GQ3,QEKN+E1 0)+Y[Y8@KE#JL;R:D&\0FRA45O,!G=TG>>.F,KD
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M].CHZ.S;;Q^=G!QNUR1Z^PSO_<]QT\=[;D/;1!C'^/2N!C4(_J'V)O\8+=<
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M:9J_=Q+Z42PK?G;GC1&3J02T!CSC.Q+SF& L_TU-T_LFR^SDP,4#-GP6)2C
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M1KLAW$WA>\T^[FW-L!Z;%3H41PHU3Z?.1=_E%O))R#$Z7S>=4-%V0:'U9%@
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MP;:$<9+JDW5MG5^3C]]!]T@#]8[YU/GEFL#]R-NL*[B6&<:UW$9C5"/]S5M
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M,X1AH-N1*\:/4;EL>*OJO+L[PQF_SG'O%\&!H&*[3XZUOY1W'/H@DMXAAF3
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MYC0]0ILAVZY2$7?U;\64A=*_LF96KXGP5!D)X/.;K.WR 1&>=T[_['ZGYRD
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M>YX2FDK8ZI24I&A8+OI,,^8J;_R.R+PX%9;,$$KO=6%X$BI^^:6\4#B&^Q\
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MDOP=J>MN='DY8<[!'*H_G0=/I5X9"Q-_*D/<=^XR1/E'EKO/JV1:JIML849
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M1;5N/LF<C4[%(X( ZELUY"E:2LF%V$,7<7H*7."KVR0M^^@23QSA2U+ $.-
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M'(_>'!_\CNC+]\,/AZ__'U!+ P04    "  ,B-Y:?U2>Y,E-  "^F0$ "0
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MLW9?\EBSZ+>\P%.69'Q;Q58XBKH@USSH@^M);.* ?%&5%; ,$A4Y!Q1=N+F
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MX8ND)$<Q.1A1YT&0V&E<52D[R-X!7^7PJJ[LA?$ 9\ Y-0,7E*_N#!C49N.
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MK([C?,D74-MM0XZ%49S,*S-V1B_8"9X?O*@M'E_/F: Q:@5#8U1GZN-Q<[U
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MJEF,ERA5.<POR3K 4$5I\ X'YHG@[:4T]'+8RBNK0.4F!Y(SB+J!11ZI/]6
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MC46-D2/,2LP*]+,RO!3Q/#:O.^/4B2(>8W_N+J![&&C@K8;F4_-+ I^1Z;!
M.&$+ *B_4!/%$5TA=5_8#S?$/I_#6*#NA8,M7UW8RZGY4NC/A13PP B5Q)%
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M!6'G7D>7MMP&%4--I!O22)Z0>+;C4]=,'A <F"$CE4SY5H,;#A14A4&UFT_
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M1[5WXS%Z%L@QW28'!@RX\QWRE?X6=2/YI7G133%N386C)SB;.R] %"_F\[C
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MDNWKF).AI7LW"CDY.PX&,RD[E$FLF\@0:5^X*X[9*R?UAA8[_!N*MN;OHH,
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M-MZ>+"A_7M,3;!?#?=!:RE<;T50'4I*'7:5+M!!,Z4V4@A4$'R;C6&NXQ#(
M3N6C4%M\L'[M@Z99@FNLQ;M$8H@\8M *Z7P1]/C7V/--+(%Y.]JL!RT$5**
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MS(;/I6QPHX1ET^ZS*5M;7ZTHRA&;&]@38F8V$Y-D96:YFP&%.UZBX;P4!4*
M$K+L1D"*:+0T44^/S!Y4B%-M[B9$FICH]]A,P[P]B/"HI#,3PXGG(:>$T'&V
MVHRCN7FAAYU!6\<RUHVLYDFFW=#%-1L+NS4V[29&:&W^&8:X"A168D)?YSZ<
M)IS8:3Q23]S(3KJ3AK@.)QFQ[LNPE1_W"D/X4.=LT\CT9=<VNR$C->#>5)O+
M]UX *XWPMOD"-HK"H+4!,UAA?%C_GN2UI02$>N;4OE,U(6-86T3),U*_&YEV
M#DE5E7_0O)JN ;VE@HA"N7"RG2(G,ET_12MZ.>L!PONETL0LHP>UZ<3UZY=1
M6"UO<<)!"-L/_5ILU';B.EQ"8@+7L"P\<[C37G2[LOH^:\/RW<SD+1-%6R#P
MCE(;1JARZN,Z%+AR.N:Q1^] TE:+5[<"C@B)3DCPSV]VOO_^3X^_Q__^2VG1
MMK]ZT-IXU,.:K-@0+R6E=Z;1'-=UMEP<BF!"!&I2'[PU(^0=U7#&C&Z2G[LT
M4K_GN+@MW<5]">N76&WB-2>X5$E)*;:.R.]3GT$KMT_^M6 /M[O_19QVI9_6
M4$H;=^1H9R]HF]#.7.X$^YFS06*/K:$A6MQ.?V?3C,).>OAVC\IPRXK+<*G#
MJ(.!55C2JF$'Y^TO99K+.X<(VV57Q4)Z$R8(19OQ=!Q*)W+(U4$P:&D=?"F!
M[4'QB^FF:MG5NLVC)*'2"IHN[*^HW]OR6U@'.A>]5DZI]))1WN!YE.0LF*?C
M!#QJ,;Z.F<6!M1Z%5(C.L#>2&7V+5)\+4<#IBC'(1!.1"VJ!42AX"L@-6C_E
M7OGU^)YU8'AO[.]EBT?C$$4FGR"WL0-OIZ9>.%#A:Q17W9NI<=\^V S=MU\S
M='_P67%/W5EQTN+QPZO#N,"3WN_M&XA6^75ZW%WDG=A@.$H(<CMFO_5LGB;M
M%63^U#=XI31N!!(<DT::F\^Q)4O$>4WNU1YG8R]/%*"FH3'TV(9*C6]4+,[O
M-%W.6CQHN/NV5.&$@1FF2\%< >PZP'S';U#P<I)U&5-;I'9E@/5EGHS5^!KG
MBV$5.GDT34>(M]:5A,"P9\WE7&DE#Z1S>+D8,O'*37P,4/X4YD: 6M'P!4)M
M$SW*9T-@X-*K.\%J#ID-A*Y7+%M7(E\,KO'P<H:5U&U/IS[5EP.F1TGT %,H
MQ>E"5"@N0:H5EK-/Y%$T3Q# Q NM.X/DQWHQK:H)W;2&H(_RC#Q\J\6UPDOA
M:)7<:0:U451@B]-#Y)JBN;PHEH8L6MKCD+C?<_T"J1AC>"PY'UY\CV.]/-GE
M^BM;Z8QH7YE+:K^A_D+CGAMFV2PH$8Q%-G/E6=IRFF=/J#MF"BV<;N^M?:OE
MSIPD U>"K=<Q.R@.()A@G#X2PK'0L7>I62.U[;+NB4,9365S6HX:>8VUE4=K
MV-V!=I2M<S XV.F(2$\@$EBS=54^E]A5V673PAJ-0$2F<-2-98&9-E[$V_Z)
M?)C@D'LPMNIL,90I3U+=';R%?47 8]DHG550ON7U]CIM8G$*@4O%HJ/87=4T
MI=XBH4AJ\@+17*:+/>GAI%J)>WBA;O5IR=%HG0D>>O&[0J&Z[#Y6A!_%EN61
MG?A$)TR/CV2.B457B=O*"Z^97D*V3+ZE]%.K2BE 4:M4B$:"RC4U$NSE.V@4
M=79K#PM]45;_N%DS,3(E>"!I1I(_](OCL!R/XCD;27B^B97/E/Z,J^XR#[!^
M)-N.:R[&IC#;]=M=0<^Q"C?^VI:NWR Z- A:])X-P.9:&!DI7V W2[ B,R-]
MIQSQM?&R(M#.I.V[DW,I>2:[5[MO:)X>.-%?!L4T6;-K PQ2W0E^MRQX[6J#
MK3IV'L1)&WB^"<!JR6,Z!7+:\XVU!5E9S<<+7H7'A*I6T4/#X5#-5*U+%]8/
M7??4M]K2VI9E^PQ6-"1JBXKL6Z .2M7N3%>D;]>^ ;5'#6PA1>,ZTY&/=L!8
M/G1JD<3#>$G\J6P@='!: *)0)M;DB7/87*XR>R;5!;PC#(5H[DI@-H49=MWA
M>YBJ_AY,<7L'2N\]*KTCU_-E+7_$(XWL5+9ZXT7?^V[TQ1 /9XR.5D$29J;-
M[QM>><T39W<;-&V,HL=3[Z*8G LHN+U6%O($6>-H\C1'Z\EYX8%-X%_U!7-#
MTU)# W6,11BHH4%I12[^+QW?-S)$@;O,,><ZF80-+S5T6OZ"-X?[,)46A8C]
MX6(CY\_.4J0FQ6G  ?ZXUY["Y0'?4FFT4&RDAORT)PI9"^L0,%173V,5NCRH
MNT7JNNM2!8,E-!U:QFTEX-Q.<!!PT[4F32V-=K,V37!=DX:A8C=MTU@OOMVD
M:5 ^1,:]OL7284M_CL%B-Y/2>:WLT;!3VFO\5IHI_V<# \5]*&Q0IWT2?$'S
MI-^KGQ37$MC*37/Y+AME122QS419\;2!A64Y(+#FM]:;)[S6V@"%:UHKND'K
MS96-CM7MC "YC>E1?WFPJ;Z_?$WUW5HQWKTWK._!_*#7BVP<S;C,^=R:7)KE
MNF9F*PQT:J\F&<"NIB+W=,F #/V-K"Z$ZZ&YS2!$AI\Z=E\I<5J.JLUB2MDP
M))8.NXD?N]8\P3SH462_N+5*(>;=_/4%"BK!6&(")DBQ!#.R:\GN<C *$<+>
MDKF8)B/L*H!278O=0U-.'C)6;ZG1%@GH(0OI;*U\P@T+T)P9(C$K+I>0+@9M
M:%)Q.BP5([#B"\'\M1%3<EO<@XW?";Z&Y@G_$CK=F":T[$K[%D^8[K'B>ODO
M6XKI;@)%?;I3%VVU/_U6.FQZB;U%YFS#S))I.VQ-8)#5+LQ9$CPN,5U^)JV.
M#34_H5;O$DE%S6\&A40CK":AW!;' APC\-GNGPR?RG:X2:%ZNK7E\LN<T*9S
M,/!,\[X1?TU3LK7D'.8!O:;3W6QYW9/4=-; DB^F49;\V\ERB,<I?S/52VVY
M9=S;15KFFK*SV]+<Z\8]DM*F8ZACFM9"T0EV]I@,;!EMM')C.8]ZZ0NBWT0]
ME#B+V8R+-=AY)O>8W]:<FT@;\5MW=K@H,8]<>EFDM7Y[;4/"QG:P[[V-OC=.
MH%?)V.I;#[0TPCV3>#67 <#%6LI),^&URWW[U1+6*%N8W!]LT95,O9'C$6R1
MP^X&!1Q%UN_5-)F?RI 4!;M()H/471C>\'+:6O%2GM*9_5*;$=#9.M ZZ'X7
MP\Z9$CG6@!2QV_NF0X>'?@='<X*U^'>=NX\GP\-FYJM[7PTVJW@UZ[!(110C
MQ%?U7B5YT9"+"<;<=$97N2@N&0SL?,L6*FOR+R)L+NCW6.Z[1>SJU!6G8+]B
MJAV>XUSGC9GC/:;]:G,R.S:!H1(N%+-)H:;>LXTP5]5+M?+(RL6LW7.*5EQK
MTYNE.B;VX#<J:V3]N\ F<#C *Y^C-"^2&OQ!D=7F33MV+O &*6E7UTGGY>8H
M>JVF,)\F[<E:L#SK#E]KN1>L7N(,+:\/ZQ37OF.=,JV'AV;1>@5^+05(9M0#
M5=&!G+F,TD6LFS).T&Y#88<*&UXML^,@.AY(2#?'$F(2@%0SYAFBF:7NY2*G
MES!5P2N-+XZ>F=DJ]%Z=M&R/-B&?\.--I+6QALX-K_39I54'G:'129ZF^97)
M,G2L$^M3&QO.S;;E3(B\H_C8<N4[!Z;%K<M#4M5K11\:.GXF_TR?TN\=TV,\
M(8;G!UA]%KLU4(Z7X?:AK:E<&3?JDD59G$T%=_5'^6C!( N$LZYO$UZ#&8T'
MON4H56'&OB*_9T+=Q"B_2#[3*+8'8VG;:.=F<*(I."?]@ +FLE%.:B3D(G-.
MV1C.TW*PH9 U<*1P90OEKADNW*F"S6<.+KH4UT-E+"*SWP%OMVD3*R@]I5U"
M51QDG'H^9K^G&9=VDBH&S#:"2Z@?B:>)" 3*A1M8[$T&8)L=T, C$B$;+,LQ
M8.JA2^**S\O ;2*M(F9M\H,K3HWJ7HV_T]W':M 5.9"5"G$S+F']H V3S<VX
M5;+D.[A4G9W VA7>_-]:RMXG\A8VX*BBCX1>I)B(C.IMUQ/=1.WW&E-85YT
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ME2!$VV0![=$(M8H]F6E(1NI>X0!12WK!.1O$(1*D3GS3)Y'H'3IAB^XGXV/
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MRW+O.OCMWNU/73)\*8)=QW>_7^NY3V+SBRD0#-&,&S$:^#T,E#+W76FJ)'J
MN^<WQNSW3-2V->IV_[?R!@R[>\8"3W>_, NHJFH-NWYY#KCU]U_% 0(5_W)Q
ML37YI;8 X)HH[J-7!]M[S3NYL-)-:OB>_7'CN=WQT%9RU?;F\<';HW]0<=F/
MYS^]>?7_ 5!+ P04    "  ,B-Y:%4_3?M%-  #BEP$ "0   &5X-'@S+FAT
M;>U]>7/;5K;G_ZSB=\!X^O43IR!9LN-TQ_9SC20KL=YS;(\E)]W5U=4%DB"%
M& 38 "B9^?1SUKM@(2EKC6UW=2216.YR[EE^9WO^ZO3GUR_ZO>>OCO9?PL\
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M$Z131(84?TU_J&9,A[P8(7@UC+*/:'Z2LD)*)QQZHX6B-(X6U1D(RM]9<RJ
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M9(-.,!*MLCS/K^U?8[^R'-)/&MC(-+;JOMP9FZ9Q"*SX;>L_8:\T7"';3TZ
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MQA2YSN*.N&O%W?VCB%'$!JG%-H:V8M5XL)4,0D>&M8&[3HVKQSO!KRZ4)HB
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MRL&$1-*K)/R&2FE-'^$V2YCA0D'-Q8AC%QVM,Y[@KI>T(ER%T9FR:".1)$C
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M:3R>JC+5XJ62QJ#M_@$_G4EZVU<N-],$>DTQTE@S;C; 45&4,&6;"A*@(>U
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MTQB[DU)[XAFB17ST)B(3,!_1^C^&&NO%V<-H7@.AHUO1!'EW^WL<ARY&"/
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M94A(GF8W.K=XN\&/CP;O/@@C*]B*V[#8YU&R(RC9)Q0HT'NR@)F"-7'^=[)
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M-C(W+GAS9%!+ 0(4 Q0    (  R(WEKS6YM8_0H  '^&   5
M  "  5H#  !A<W1I+3(P,C4P-C(W7VQA8BYX;6Q02P$"% ,4    "  ,B-Y:
M.9.^YE<'  #:5P  %0              @ &*#@  87-T:2TR,#(U,#8R-U]P
M<F4N>&UL4$L! A0#%     @ #(C>6JV:V Q\&0  RXD   L
M ( !%!8  &%S=&E?.&LN:'1M4$L! A0#%     @ #(C>6@Y0AJ*3F   PA8#
M  H              ( !N2\  &5X,3!X,2YH=&U02P$"% ,4    "  ,B-Y:
M?U2>Y,E-  "^F0$ "0              @ %TR   97@T>#$N:'1M4$L! A0#
M%     @ #(C>6I?"'^R%2   O(,!  D              ( !9!8! &5X-'@R
M+FAT;5!+ 0(4 Q0    (  R(WEH53]-^T4T  .*7 0 )              "
M 1!? 0!E>#1X,RYH=&U02P$"% ,4    "  ,B-Y:G'JHIF8*  #D&P  "@
M            @ $(K0$ 97@Y.7@Q+FAT;5!+!08     "0 ) !,"  "6MP$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>asti_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asti-20250627.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001350102</identifier>
        </entity>
        <period>
            <startDate>2025-06-27</startDate>
            <endDate>2025-06-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-27" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-27" id="Fact000004">0001350102</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-27" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-27" id="Fact000010">2025-06-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-27" id="Fact000011">ASCENT SOLAR TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-27" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-27" id="Fact000013">001-32919</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-27" id="Fact000014">20-3672603</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-27" id="Fact000015">12300 Grant Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-27" id="Fact000016">Thornton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-27" id="Fact000017">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-27" id="Fact000018">80241</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-27" id="Fact000019">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-27" id="Fact000020">872-5000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-27" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-27" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-27" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-27" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-27" id="Fact000025">Common</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-27" id="Fact000026">ASTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-27" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-27" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
